NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,266,813 | +315.2% | 132,330 | +278.8% | 0.00% | – |
| Q1 2024 | $545,956 | -4.1% | 34,930 | -8.4% | 0.00% | – |
| Q4 2023 | $569,311 | +3.0% | 38,132 | +11.4% | 0.00% | – |
| Q3 2023 | $552,863 | -61.9% | 34,233 | -2.0% | 0.00% | -100.0% |
| Q2 2023 | $1,449,222 | -28.2% | 34,921 | +4.1% | 0.00% | 0.0% |
| Q1 2023 | $2,017,938 | -38.2% | 33,554 | -24.6% | 0.00% | 0.0% |
| Q4 2022 | $3,265,762 | -2.7% | 44,523 | +0.8% | 0.00% | -50.0% |
| Q3 2022 | $3,356,000 | +8.5% | 44,168 | -0.8% | 0.00% | +100.0% |
| Q2 2022 | $3,093,000 | -17.1% | 44,509 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $3,729,000 | +8.2% | 45,013 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $3,447,000 | -50.3% | 45,905 | -23.1% | 0.00% | -66.7% |
| Q3 2021 | $6,932,000 | -42.0% | 59,667 | +10.8% | 0.00% | -40.0% |
| Q2 2021 | $11,943,000 | +58.4% | 53,841 | -5.6% | 0.01% | +66.7% |
| Q1 2021 | $7,540,000 | -23.0% | 57,041 | +0.8% | 0.00% | -40.0% |
| Q4 2020 | $9,796,000 | +67.1% | 56,611 | +7.5% | 0.01% | +66.7% |
| Q3 2020 | $5,862,000 | +37.6% | 52,661 | -26.7% | 0.00% | 0.0% |
| Q2 2020 | $4,261,000 | -65.5% | 71,861 | -60.8% | 0.00% | -66.7% |
| Q1 2020 | $12,344,000 | -19.0% | 183,310 | +1.4% | 0.01% | 0.0% |
| Q4 2019 | $15,237,000 | +39.1% | 180,810 | +23.4% | 0.01% | +28.6% |
| Q3 2019 | $10,957,000 | +43.1% | 146,520 | +21.0% | 0.01% | +40.0% |
| Q2 2019 | $7,657,000 | +47.6% | 121,100 | +12.4% | 0.01% | +66.7% |
| Q1 2019 | $5,188,000 | +45.5% | 107,700 | +1.1% | 0.00% | 0.0% |
| Q4 2018 | $3,566,000 | -36.4% | 106,500 | -0.5% | 0.00% | -25.0% |
| Q3 2018 | $5,607,000 | +68.4% | 107,000 | +0.6% | 0.00% | +100.0% |
| Q2 2018 | $3,330,000 | +88.1% | 106,400 | +31.0% | 0.00% | +100.0% |
| Q1 2018 | $1,770,000 | +14.0% | 81,200 | +5.6% | 0.00% | 0.0% |
| Q4 2017 | $1,553,000 | +1.8% | 76,900 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,526,000 | +16.7% | 76,900 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $1,308,000 | +175.4% | 75,600 | +28.8% | 0.00% | – |
| Q1 2017 | $475,000 | -5.0% | 58,700 | -7.8% | 0.00% | – |
| Q4 2016 | $500,000 | -19.5% | 63,700 | -12.4% | 0.00% | -100.0% |
| Q3 2016 | $621,000 | -26.8% | 72,700 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $848,000 | +205.0% | 72,700 | +278.6% | 0.00% | – |
| Q1 2016 | $278,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $25,951,950 | 11.32% |
| Invus Financial Advisors, LLC | 350,884 | $6,010,643 | 6.74% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 66,892 | $1,145,860 | 1.44% |
| Palo Alto Investors LP | 561,908 | $9,625,484 | 1.12% |
| Taylor Frigon Capital Management LLC | 133,298 | $2,283,395 | 1.09% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 161,486 | $2,766,255 | 0.52% |
| Birchview Capital, LP | 20,000 | $342,600 | 0.32% |
| PDT Partners, LLC | 188,422 | $3,227,669 | 0.31% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,028,331 | $17,615,312 | 0.17% |
| Soleus Capital Management, L.P. | 108,900 | $1,865,457 | 0.16% |